Showing results (51-60 of 344) with videos related to
Sort By:
Pageof 35
Medical Science Monitor Basic Research|September 18, 2014
Sirtuin 1 activity in peripheral blood mononuclear cells of patients with osteoporosisMarie Godfrin-Valnet, Kashif A Khan, Xavier Guillot, et al.Arthritis Research & Therapy|July 27, 2013
New autoantibodies in early rheumatoid arthritisCaroline Charpin, Fanny Arnoux, Marielle Martin, et al.Joint Bone Spine|February 23, 2010
Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practiceEric Toussirot, Edouard Pertuiset, Christelle Sordet, et al.Best Practice & Research. Clinical Rheumatology|November 26, 2008
Epstein-Barr virus in autoimmune diseasesEric Toussirot, Jean RoudierDrugs & Aging|October 30, 2023
Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older PatientsRenaud Felten, Eric ToussirotRheumatology (Oxford, England)|November 24, 2020
Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular riskEric Toussirot, François Aubin, Maxime Desmarets, et al.Joint Bone Spine|July 13, 2007
Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an updateEric Toussirot, Jean RoudierExpert Opinion on Biological Therapy|August 17, 2024
IL-17 inhibitors in axial spondyloarthritis. An overviewEric Toussirot, Renaud FeltenThe Journal of Rheumatology|October 3, 2009
Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case seriesEric Toussirot, Jean Marie Berthelot, Edouard Pertuiset, et al.EULAR Rheumatology Open|June 29, 2026
Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotypeJuliane Michel, Clément Prati, Lucine Vuitton, et al.Pageof 35